CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 4 Planned sale CEO and President sold 3,117 shares at an average $0.36 ($1,131)
- 4 Planned sale Chief Financial Officer sold 577 shares at an average $0.36 ($207)
- 4 Planned sale See Remarks sold 430 shares at an average $0.36 ($153)
- 4 Planned sale Chief Scientific Officer sold 430 shares at an average $0.35 ($152)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4/A Option exercise Director acquired 27,089 shares (option exercise)
- 4 Option exercise Director acquired 27,089 shares (option exercise)
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 9 of 34 · 672 filings